Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
ObjectiveThis article investigates the role of Transgelin (TAGLN) in the epithelial–mesenchymal transition (EMT) of esophageal squamous cell carcinomas (ESCC) and its possible mechanism of inhibiting the invasion of these cancers.MethodsTissue specimens and clinical information of patients with ESCC...
| Päätekijät: | Boli Yang, Qiuyu Chen, Changshan Wan, Siyuan Sun, Lanping Zhu, Zhizhong Zhao, Weilong Zhong, Bangmao Wang |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Frontiers Media S.A.
2021-08-01
|
| Sarja: | Frontiers in Oncology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fonc.2021.709486/full |
Samankaltaisia teoksia
-
Corrigendum: Transgelin Inhibits the Malignant Progression of Esophageal Squamous Cell Carcinomas by Regulating Epithelial–Mesenchymal Transition
Tekijä: Boli Yang, et al.
Julkaistu: (2022-03-01) -
BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial–mesenchymal transition and angiogenesis
Tekijä: Yan Zhao, et al.
Julkaistu: (2021-05-01) -
Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
Tekijä: Zongdan Jiang, et al.
Julkaistu: (2021-11-01) -
Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer
Tekijä: Yan Sun, et al.
Julkaistu: (2018-07-01) -
Serum transgelin is a novel prognostic biomarker for COVID-19 patients
Tekijä: Lei Gao, et al.
Julkaistu: (2024-11-01)